Literature DB >> 12051639

Effect of prolonged formalin fixation on the immunohistochemical reactivity of breast markers.

Daniel A Arber1.   

Abstract

Prolonged formalin fixation is known to reduce the immunohistochemical reactivity of many paraffin section antibodies. Before the common use of heat induced epitope retrieval methods, vimentin reactivity was proposed as a marker of antigen preservation. To evaluate the effect of formalin fixation on breast tumor markers, multitumor blocks of tissue fixed in formalin for varying time intervals from 33 different infiltrating breast carcinomas were analyzed for the expression of estrogen receptor (ER), progesterone receptor (PR), c-erb-B2, Ki-67, p27, and vimentin. The mean/median length of the longest fixation time per specimen was 53/42 days (range 7 days-154 days). Formalin fixation did not significantly reduce immunoreactivity for Ki-67, p27, or vimentin, even in tissue fixed for 154 days. Of 23 ER-positive cases, a significant reduction in immunoreactivity (2 grades or more) was identified in three samples, occurring at 57 to 64 days. For 21 PR-positive cases, only one showed a significant reduction (from 3+ to 1+) at 120 days. Of nine c-erb-B2 positive (2 + or 3+) cases, four became negative (1+ or 0) at 20, 42, 49, and 99 days. The immunoreactivity of some breast prognostic markers is reduced by formalin over-fixation, but only after extensive fixation that may not be clinically relevant. The loss of antigen preservation is not accompanied by a loss of vimentin immunoreactivity, making vimentin a suboptimal marker for ER, PR, or c-erb-B2 preservation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12051639     DOI: 10.1097/00129039-200206000-00015

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  21 in total

Review 1.  The efficient operation of the surgical pathology gross room.

Authors:  W C Bell; E S Young; P E Billings; W E Grizzle
Journal:  Biotech Histochem       Date:  2008-04       Impact factor: 1.718

Review 2.  Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades.

Authors:  Shan-Rong Shi; Yan Shi; Clive R Taylor
Journal:  J Histochem Cytochem       Date:  2011-01       Impact factor: 2.479

Review 3.  Obstacles to precision oncology: confronting current factors affecting the successful introduction of biomarkers to the clinic.

Authors:  Ludmila Prudkin; Paolo Nuciforo
Journal:  Cell Oncol (Dordr)       Date:  2014-09-04       Impact factor: 6.730

4.  Pathological characteristics of BRCA-associated breast cancers in Hispanics.

Authors:  Veronica I Lagos-Jaramillo; Michael F Press; Charité N Ricker; Louis Dubeau; Phuong L Mai; Jeffrey N Weitzel
Journal:  Breast Cancer Res Treat       Date:  2011-05-21       Impact factor: 4.872

5.  The effect of prolonged cold ischemia time on estrogen receptor immunohistochemistry in breast cancer.

Authors:  Xiaoxian Li; Michael T Deavers; Ming Guo; Ping Liu; Yun Gong; Constance T Albarracin; Lavinia P Middleton; Lei Huo
Journal:  Mod Pathol       Date:  2012-08-17       Impact factor: 7.842

6.  Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort.

Authors:  Elizabeth N Kornaga; Alexander C Klimowicz; Natalia Guggisberg; Travis Ogilvie; Don G Morris; Marc Webster; Anthony M Magliocco
Journal:  Mod Pathol       Date:  2016-08-26       Impact factor: 7.842

7.  Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping.

Authors:  Julia D Wulfkuhle; Daniela Berg; Claudia Wolff; Rupert Langer; Kai Tran; Julie Illi; Virginia Espina; Mariaelena Pierobon; Jianghong Deng; Angela DeMichele; Axel Walch; Holger Bronger; Ingrid Becker; Christine Waldhör; Heinz Höfler; Laura Esserman; Lance A Liotta; Karl-Friedrich Becker; Emanuel F Petricoin
Journal:  Clin Cancer Res       Date:  2012-10-08       Impact factor: 12.531

Review 8.  Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens-A review and evidence-based guide.

Authors:  Aditi Bhatt; Suniti Mishra; Loma Parikh; Sandeep Sheth; Imran Gorur
Journal:  Indian J Surg Oncol       Date:  2019-03-19

9.  Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.

Authors:  Mitch Dowsett; Torsten O Nielsen; Roger A'Hern; John Bartlett; R Charles Coombes; Jack Cuzick; Matthew Ellis; N Lynn Henry; Judith C Hugh; Tracy Lively; Lisa McShane; Soon Paik; Frederique Penault-Llorca; Ljudmila Prudkin; Meredith Regan; Janine Salter; Christos Sotiriou; Ian E Smith; Giuseppe Viale; Jo Anne Zujewski; Daniel F Hayes
Journal:  J Natl Cancer Inst       Date:  2011-09-29       Impact factor: 13.506

10.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; David G Hicks; Mitch Dowsett; Lisa M McShane; Kimberly H Allison; Donald C Allred; John M S Bartlett; Michael Bilous; Patrick Fitzgibbons; Wedad Hanna; Robert B Jenkins; Pamela B Mangu; Soonmyung Paik; Edith A Perez; Michael F Press; Patricia A Spears; Gail H Vance; Giuseppe Viale; Daniel F Hayes
Journal:  Arch Pathol Lab Med       Date:  2013-10-07       Impact factor: 5.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.